Products for Research Use Only
RegisterLogin

EGFR/HDAC-IN-2

CAT: 0013-GTR19273016-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19273016-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
EGFR/HDAC-IN-2 (Compound 38) is a dual inhibitor of EGFR and HDAC3, exhibiting IC50 values of 20.34 nM and 1.09 nM, respectively. This compound demonstrates exceptional antiproliferative activity against cancer cells, inhibiting cell migration and inducing late-stage apoptosis. In xenograft mouse models, EGFR/HDAC-IN-2 significantly suppresses the growth of triple-negative breast cancer (TNBC) tumors and is applicable in research on cancers such as TNBC.
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19257593-01EGFR/HDAC-IN-1
GTR19238592-01FLT3/HDAC-IN-2
GTR19230993-01JAK/HDAC-IN-2
GTR19230529-01Tubulin/HDAC-IN-2
GTR19274878-01ALK/HDAC-IN-2
GTR19184967-01CDK/HDAC-IN-2
GTR19274767-01HDAC/HSP90-IN-2
GTR19249331-01ROCK/HDAC-IN-2
GTR19239026-01STAT3/HDAC-IN-2
GTR19280631-01HDAC degrader-2

Alternative Products

CatalogName
HY-175805EGFR/HDAC-IN-2
T207649-01EGFR/HDAC-IN-1
B2933-25HDAC, EGFR & HER2 inhibitor
bs-60092C-01CUDC-101, HDAC/EGFR/HER2 Inhibitor
TBI2491-25MGCUDC-101, Dual HDAC and EGFR inhibitor
HY-115585HDAC-IN-2
20R-1662HDAC 2 antibody
HY-145852Top/HDAC-IN-2
HY-169938LSD1/HDAC-IN-2
HY-146276CDK/HDAC-IN-2

Popular Products